CRISPR Therapeutics AG (CRSP) Non Operating Income (2016 - 2025)
Historic Non Operating Income for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q4 2025 value amounting to $24.8 million.
- CRISPR Therapeutics AG's Non Operating Income fell 1148.09% to $24.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $86.6 million, marking a year-over-year decrease of 1664.49%. This contributed to the annual value of $86.6 million for FY2025, which is 1664.57% down from last year.
- According to the latest figures from Q4 2025, CRISPR Therapeutics AG's Non Operating Income is $24.8 million, which was down 1148.09% from $26.2 million recorded in Q3 2025.
- Over the past 5 years, CRISPR Therapeutics AG's Non Operating Income peaked at $28.0 million during Q4 2024, and registered a low of $363000.0 during Q1 2022.
- In the last 5 years, CRISPR Therapeutics AG's Non Operating Income had a median value of $16.0 million in 2023 and averaged $14.5 million.
- Per our database at Business Quant, CRISPR Therapeutics AG's Non Operating Income crashed by 8143.22% in 2022 and then soared by 341019.28% in 2023.
- CRISPR Therapeutics AG's Non Operating Income (Quarter) stood at $2.2 million in 2021, then surged by 422.99% to $11.5 million in 2022, then soared by 74.04% to $20.0 million in 2023, then surged by 39.91% to $28.0 million in 2024, then decreased by 11.48% to $24.8 million in 2025.
- Its Non Operating Income stands at $24.8 million for Q4 2025, versus $26.2 million for Q3 2025 and $22.1 million for Q2 2025.